{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:30:20Z","timestamp":1780061420243,"version":"3.54.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.clinthera.2011.09.012","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T18:18:31Z","timestamp":1318875511000},"source":"Crossref","is-referenced-by-count":3,"title":["The Perception and Pharmacokinetics of a 20-mg Dose of Escitalopram Orodispersible Tablets in a Relative Bioavailability Study in Healthy Men"],"prefix":"10.1016","clinical-trial-number":[{"clinical-trial-number":"nct01395433","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Dorrit \u00d8stergaard","family":"Nilausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.G.J.A.","family":"Zuiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop van","family":"Gerven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.09.012_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i6.10","article-title":"Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies","volume":"21","author":"Fu","year":"2004","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.clinthera.2011.09.012_bib2","first-page":"947","article-title":"Problems when swallowing tablets. A questionnaire study from general practice [in Norwegian]","volume":"115","author":"Andersen","year":"1995","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/j.clinthera.2011.09.012_bib3","first-page":"55","article-title":"Swallowing problems in the normal ageing population","volume":"46","author":"Wilkinson","year":"1999","journal-title":"S Afr J Commun Disord"},{"key":"10.1016\/j.clinthera.2011.09.012_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2702.2004.00967.x","article-title":"Artificial hydration and nutrition in advances Alzheimer's disease: facilitating family decision making","volume":"13","author":"Eggenberger","year":"2004","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.clinthera.2011.09.012_bib5","first-page":"1041","article-title":"Rehabilitation medicines: diagnosis of dysphagia and its nutritional management for stroke patients","volume":"169","author":"Finestone","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.clinthera.2011.09.012_bib6","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2214\/ajr.156.6.2028863","article-title":"Altered swallowing function in elderly patients without dysphagia: radiologic findings in 56 cases","volume":"156","author":"Ekberg","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clinthera.2011.09.012_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3109\/15622975.2010.505663","article-title":"Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study","volume":"11","author":"Bitter","year":"2010","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2011.09.012_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0378-5173(01)00722-0","article-title":"The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water","volume":"222","author":"Perkins","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clinthera.2011.09.012_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/j.1552-4604.1986.tb02922.x","article-title":"The effect of size and shape of tablets on their esophageal transit","volume":"26","author":"Channer","year":"1986","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2011.09.012_bib10","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0149-2918(03)80163-7","article-title":"Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers","volume":"25","author":"van Schaick","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2011.09.012_bib11","author":"Hirani"},{"key":"10.1016\/j.clinthera.2011.09.012_bib12","unstructured":"European Pharmacopoeia. European Department for the Quality of Medicines. 3rd ed. Strasbourg, pp. 1666\u20131669 Supplement 2001."},{"key":"10.1016\/j.clinthera.2011.09.012_bib13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/0269881110374782","article-title":"What one hand giveth the other taketh away: some unpredicted effects of enantiomers in psychopharmacology","volume":"24","author":"Nutt","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2011.09.012_bib14","doi-asserted-by":"crossref","unstructured":"World Medical Association (WMA). Declaration of Helsinki: Ethical principles for medical research involving human subjects adopted by the 18th WMA General Assembly, Helsinki, Finland June 1964 and latest revised, Souel, Korea, 2008.","DOI":"10.1515\/9783110208856.233"},{"key":"10.1016\/j.clinthera.2011.09.012_bib16","unstructured":"US Food and Drug Administration. Guidance for Industry. Bioanalytical Method Validation. May 2001. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm070107.pdf. Accessed April 15, 2011."},{"key":"10.1016\/j.clinthera.2011.09.012_bib17","unstructured":"Rowland M and Tozer T. Clinical Pharmacokinetics, Concepts and Applications. 1995, Third Edition."},{"key":"10.1016\/j.clinthera.2011.09.012_bib18","first-page":"S51","article-title":"Sample size determination for bioequivalence assessments by means of confidence intervals","volume":"30","author":"Diletti","year":"1992","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1016\/j.clinthera.2011.09.012_bib21","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1177\/0091270005280860","article-title":"The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects","volume":"45","author":"Sogaard","year":"2005","journal-title":"J Clin Pharmacol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811006205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T19:42:07Z","timestamp":1560800527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811006205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":18,"alternative-id":["S0149291811006205"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.09.012","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}